AbbVie, Inc. (ABBV)
207.94
-4.46
(-2.10%)
USD |
NYSE |
Apr 10, 16:00
208.77
+0.83
(+0.40%)
After-Hours: 20:00
AbbVie Free Cash Flow : 17.82B for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Amgen, Inc. | 8.10B |
| Biogen, Inc. | 1.969B |
| Gilead Sciences, Inc. | 9.456B |
| Johnson & Johnson | 19.70B |
| Regeneron Pharmaceuticals, Inc. | 3.765B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 5.218B |
| Cash from Investing (Quarterly) | -1.463B |
| Cash from Financing (Quarterly) | -4.166B |
| Free Cash Flow Per Share (Quarterly) | 2.756 |
| Free Cash Flow to Equity (Quarterly) | 5.447B |
| Free Cash Flow to Firm (Quarterly) | 5.404B |
| Free Cash Flow Yield | 4.83% |